Determination of haloperidol in human serum by radioimmunoassay. 1980

H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh

A radioimmunoassay has been developed which enables accurate determination of haloperidol in human serum. Antiserum was prepared by immunizing guinea pigs with haloperidol (O-carboxymethyl)oxime derivative (III) coupled with bovine serum albumin. With the antiserum, 3H-haloperidol and dextran-coated charcoal, the assay of haloperidol in serum was possible over a concentration range of 1 to 50 ng/ml, using 0.1 ml of human serum without the need of an extraction procedure. Data obtained by radioimmunoassay are in good agreement with those obtained by gas chromatography. No appreciable cross-reactivity was observed neither with haloperidol metabolites nor with other butyrophenone neuroleptics. Serum levels of haloperidol in schizophrenic patients receiving single oral dosing (6 mg/subject) have also been determined.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006241 Haptens Small antigenic determinants capable of eliciting an immune response only when coupled to a carrier. Haptens bind to antibodies but by themselves cannot elicit an antibody response. Hapten,Contact-Sensitizing Agents,Agents, Contact-Sensitizing,Contact Sensitizing Agents
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D012710 Serum Albumin, Bovine Serum albumin from cows, commonly used in in vitro biological studies. (From Stedman, 25th ed) Fetal Bovine Serum,Fetal Calf Serum,Albumin Bovine,Bovine Albumin,Bovine Serum Albumin,Albumin, Bovine,Albumin, Bovine Serum,Bovine Serum, Fetal,Bovine, Albumin,Calf Serum, Fetal,Serum, Fetal Bovine,Serum, Fetal Calf

Related Publications

H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
June 1984, Radioisotopes,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
January 1977, Life sciences,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
November 1981, Life sciences,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
January 1981, International pharmacopsychiatry,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
May 1990, Journal of pharmaceutical sciences,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
January 1977, The Journal of biological chemistry,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
August 1975, Cancer research,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
November 1981, Ceskoslovenska farmacie,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
January 1979, The American journal of physiology,
H Suzuki, and Y Minaki, and M Iwaisaki, and Y Sekine, and A Kagemoto, and Y Utsui, and M Hashimoto, and G Yagi, and H Itoh
January 1976, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!